References
47
Hamoud R, Zimmermann S, Reichling J et al. (2014) Synergistic interactions in two-drug and
three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria
including E. coli. Phytomedicine 21 (4):443–447
Haynes KM, Abdali N, Jhawar V et al. (2017) Identification and structure-activity relationships of
novel compounds that potentiate the activities of antibiotics in Escherichia coli. J Med Chem 60
(14):6205–6219
Hecker SJ, Reddy KR, Lomovskaya O et al. (2020) Discovery of cyclic boronic acid QPX7728, an
ultrabroad-spectrum inhibitor of serine and metallo-β-lactamases. J Med Chem 63 (14):7491–
7507
Hecker SJ, Reddy KR, Totrov M et al. (2015) Discovery of a cyclic boronic acid β-lactamase inhibitor
(RPX7009) with utility vs class A serine carbapenemases. J Med Chem 58 (9):3682–3692
Hernandez V, Akama T, Li X et al. (2016) Boron in medicinal chemistry. In: Desai MC (ed -inchief) 2016 Medicinal chemistry reviews, vol 51. Medicinal Chemistry Division of the American
Chemical Society, Washington, pp 329–345
Hong DJ, Bae IK, Jang IH et al. (2015) Epidemiology and characteristics of metallo-β-lactamaseproducing Pseudomonas aeruginosa. Infect Chemother 47 (2):81–97
Hu Q, Peng Z, Li L et al. (2020) The efficacy of berberine-containing quadruple therapy on Helicobacter pylori eradication in China: A systematic review and meta-analysis of randomized
clinical trials. Front Pharmacol 10 (1694)
Huang L, Szewczyk G, Sarna T et al. (2017) Potassium iodide potentiates broad-spectrum
antimicrobial photodynamic inactivation using Photofrin. ACS Infect Dis 3:320–328
Janardhanan J, Bouley R, Martínez-Caballero S et al. (2019) The quinazolinone allosteric inhibitor of
PBP 2a synergizes with Piperacillin and Tazobactam against Methicillin-resistant Staphylococcus
aureus. Antimicrob Agents Chemother 63 (5):e02637–18
Jia J, Zhu F, Ma X et al. (2009) Mechanisms of drug combinations: interaction and network
perspectives. Nat Rev Drug Discov 8 (2):111–128
Jindal HM, Zandi K, Ong KC et al. (2017) Mechanisms of action and in vivo antibacterial efficacy assessment of five novel hybrid peptides derived from indolicidin and ranalexin against
Streptococcus pneumoniae. PeerJ 5:e3887, doi: https://doi.org/10.7717/peerj.3887
Jindal S, Yang L, Day PJ et al. (2019) Involvement of multiple influx and efflux transporters in the
accumulation of cationic fluorescent dyes by Escherichia coli. BMC Microbiol 19 (1):195
Kanagasundaram T, Timmermann A, Kramer CS et al. (2019) A new approach to silicon rhodamines
by Suzuki-Miyaura coupling - scope and limitations. Beilstein J Org Chem 15:2569–2576
Klaue K, Garmshausen Y, Hecht S (2018) Taking photochromism beyond visible: direct one-photon
NIR photoswitches operating in the biological window. Angew Chem Int Ed Engl 57 (5):1414–
1417
Kotani K, Matsumura M, Morita Y et al. (2019) 13-(2-Methylbenzyl)berberine is a more potent
inhibitor of MexXY-dependent aminoglycoside resistance than Berberine. Antibiotics (Basel) 8
(4):212
Krajnc A, Lang PA, Panduwawala TD et al. (2019) Will morphing boron-based inhibitors beat the
β-lactamases? Curr Opin Chem Biol 50:101–110
Laudadio E, Cedraro N, Mangiaterra G et al. (2019) Natural alkaloid berberine activity against
Pseudomonas aeruginosa MexXY-mediated aminoglycoside resistance: in silico and in vitro
studies. J Nat Prod 82 (7):1935–1944
Lee Y, Kim J, Trinh S (2019) Meropenem-Vaborbactam (Vabomere TM ): Another option for
carbapenem-resistant Enterobacteriaceae. Pharm Ther (P&T ® ) 44(3):110–113
Lewis K (2020) The science of antibiotic discovery. Cell 181 (1):29–45
Linciano P, Cendron L, Gianquinto E et al. (2019) Ten years with New delhi Metallo-β-lactamase-1
(NDM-1): from structural insights to inhibitor design. ACS Infect Dis 5 (1):9–34
Liu Y, Qin R, Zaat SAJ et al. (2015) Antibacterial photodynamic therapy: Overview of a promising
approach to fight antibiotic-resistant bacterial infections. J Clin Transl Res 1(3):140–167
47
Hamoud R, Zimmermann S, Reichling J et al. (2014) Synergistic interactions in two-drug and
three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria
including E. coli. Phytomedicine 21 (4):443–447
Haynes KM, Abdali N, Jhawar V et al. (2017) Identification and structure-activity relationships of
novel compounds that potentiate the activities of antibiotics in Escherichia coli. J Med Chem 60
(14):6205–6219
Hecker SJ, Reddy KR, Lomovskaya O et al. (2020) Discovery of cyclic boronic acid QPX7728, an
ultrabroad-spectrum inhibitor of serine and metallo-β-lactamases. J Med Chem 63 (14):7491–
7507
Hecker SJ, Reddy KR, Totrov M et al. (2015) Discovery of a cyclic boronic acid β-lactamase inhibitor
(RPX7009) with utility vs class A serine carbapenemases. J Med Chem 58 (9):3682–3692
Hernandez V, Akama T, Li X et al. (2016) Boron in medicinal chemistry. In: Desai MC (ed -inchief) 2016 Medicinal chemistry reviews, vol 51. Medicinal Chemistry Division of the American
Chemical Society, Washington, pp 329–345
Hong DJ, Bae IK, Jang IH et al. (2015) Epidemiology and characteristics of metallo-β-lactamaseproducing Pseudomonas aeruginosa. Infect Chemother 47 (2):81–97
Hu Q, Peng Z, Li L et al. (2020) The efficacy of berberine-containing quadruple therapy on Helicobacter pylori eradication in China: A systematic review and meta-analysis of randomized
clinical trials. Front Pharmacol 10 (1694)
Huang L, Szewczyk G, Sarna T et al. (2017) Potassium iodide potentiates broad-spectrum
antimicrobial photodynamic inactivation using Photofrin. ACS Infect Dis 3:320–328
Janardhanan J, Bouley R, Martínez-Caballero S et al. (2019) The quinazolinone allosteric inhibitor of
PBP 2a synergizes with Piperacillin and Tazobactam against Methicillin-resistant Staphylococcus
aureus. Antimicrob Agents Chemother 63 (5):e02637–18
Jia J, Zhu F, Ma X et al. (2009) Mechanisms of drug combinations: interaction and network
perspectives. Nat Rev Drug Discov 8 (2):111–128
Jindal HM, Zandi K, Ong KC et al. (2017) Mechanisms of action and in vivo antibacterial efficacy assessment of five novel hybrid peptides derived from indolicidin and ranalexin against
Streptococcus pneumoniae. PeerJ 5:e3887, doi: https://doi.org/10.7717/peerj.3887
Jindal S, Yang L, Day PJ et al. (2019) Involvement of multiple influx and efflux transporters in the
accumulation of cationic fluorescent dyes by Escherichia coli. BMC Microbiol 19 (1):195
Kanagasundaram T, Timmermann A, Kramer CS et al. (2019) A new approach to silicon rhodamines
by Suzuki-Miyaura coupling - scope and limitations. Beilstein J Org Chem 15:2569–2576
Klaue K, Garmshausen Y, Hecht S (2018) Taking photochromism beyond visible: direct one-photon
NIR photoswitches operating in the biological window. Angew Chem Int Ed Engl 57 (5):1414–
1417
Kotani K, Matsumura M, Morita Y et al. (2019) 13-(2-Methylbenzyl)berberine is a more potent
inhibitor of MexXY-dependent aminoglycoside resistance than Berberine. Antibiotics (Basel) 8
(4):212
Krajnc A, Lang PA, Panduwawala TD et al. (2019) Will morphing boron-based inhibitors beat the
β-lactamases? Curr Opin Chem Biol 50:101–110
Laudadio E, Cedraro N, Mangiaterra G et al. (2019) Natural alkaloid berberine activity against
Pseudomonas aeruginosa MexXY-mediated aminoglycoside resistance: in silico and in vitro
studies. J Nat Prod 82 (7):1935–1944
Lee Y, Kim J, Trinh S (2019) Meropenem-Vaborbactam (Vabomere TM ): Another option for
carbapenem-resistant Enterobacteriaceae. Pharm Ther (P&T ® ) 44(3):110–113
Lewis K (2020) The science of antibiotic discovery. Cell 181 (1):29–45
Linciano P, Cendron L, Gianquinto E et al. (2019) Ten years with New delhi Metallo-β-lactamase-1
(NDM-1): from structural insights to inhibitor design. ACS Infect Dis 5 (1):9–34
Liu Y, Qin R, Zaat SAJ et al. (2015) Antibacterial photodynamic therapy: Overview of a promising
approach to fight antibiotic-resistant bacterial infections. J Clin Transl Res 1(3):140–167